Judi Weissinger

622 total citations
22 papers, 448 citations indexed

About

Judi Weissinger is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Physiology. According to data from OpenAlex, Judi Weissinger has authored 22 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Judi Weissinger's work include Pharmacogenetics and Drug Metabolism (5 papers), Pharmaceutical studies and practices (5 papers) and Immunotoxicology and immune responses (2 papers). Judi Weissinger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Pharmaceutical studies and practices (5 papers) and Immunotoxicology and immune responses (2 papers). Judi Weissinger collaborates with scholars based in United States, Switzerland and Germany. Judi Weissinger's co-authors include Daniel E. Furst, Carl C. Peck, Vinod P. Shah, Robert E. Desjardins, Jerry M. Collins, Donald R. Stanski, Jerome J. Schentag, Robert J. Temple, William H. Barr and Gerhard Levy and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biotechnology Advances and Pharmaceutical Research.

In The Last Decade

Judi Weissinger

21 papers receiving 406 citations

Peers

Judi Weissinger

PHARM

PPCH

ONCOL

James A. Oppermann United States

B. Jones United Kingdom

Eleanor Howgate United Kingdom

Ryosei Kawai Japan

I. Gardner United Kingdom

John Dikran Balian United States

Stephan Schaller Germany

Shiew Mei Huang United States

Lilly Xu United States

James A. Oppermann United States

Judi Weissinger

49 ×0.4

PHARM

100 ×1.1

60 ×0.7

46 ×0.6

PPCH

29 ×0.4

ONCOL

Citations per year, relative to Judi Weissinger Judi Weissinger (= 1×) peers James A. Oppermann

Countries citing papers authored by Judi Weissinger

Since Specialization

Citations

This map shows the geographic impact of Judi Weissinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judi Weissinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judi Weissinger more than expected).

Fields of papers citing papers by Judi Weissinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judi Weissinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judi Weissinger. The network helps show where Judi Weissinger may publish in the future.

Co-authorship network of co-authors of Judi Weissinger

This figure shows the co-authorship network connecting the top 25 collaborators of Judi Weissinger. A scholar is included among the top collaborators of Judi Weissinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judi Weissinger. Judi Weissinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1994). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. The Journal of Clinical Pharmacology. 34(2). 111–119. 37 indexed citations

Weissinger, Judi. (1994). A Systems Approach to Quality Auditing. Drug Information Journal. 28(4). 1085–1087. 1 indexed citations

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Journal of Pharmaceutical Sciences. 81(6). 605–610. 49 indexed citations

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clinical Pharmacology & Therapeutics. 51(4). 465–473. 141 indexed citations

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Pharmaceutical Research. 9(6). 826–833. 41 indexed citations

Weissinger, Judi. (1992). Clinical Pathology Testing in Preclinical Safety Assessment: Regulatory Concerns. Toxicologic Pathology. 20(3-2). 509–514. 6 indexed citations

Weissinger, Judi, et al.. (1991). Regulatory Science of Chlorofluorocarbon Replacement. Journal of Aerosol Medicine. 4(3). 201–203. 2 indexed citations

Weissinger, Judi. (1990). Pharmacology and Toxicology of Novel Drug Delivery Systems. Drug Safety. 5(Supplement 1). 107–113. 5 indexed citations

Weissinger, Judi. (1990). Nonclinical regulatory considerations for wound‐healing growth factors. Drug Development Research. 19(3). 275–283. 7 indexed citations

10.

Weissinger, Judi. (1989). Preclinical and pharmacology and toxicology of hematopoietic growth factors. Biotechnology Advances. 7(3). 387–399. 4 indexed citations

11.

Weissinger, Judi. (1989). Nonclinical pharmacologic and toxicologic considerations for evaluating biologic products. Regulatory Toxicology and Pharmacology. 10(3). 255–263. 6 indexed citations

12.

Weissinger, Judi. (1989). Considerations in the Development of Stereoisomeric Drugs: FDA Viewpoint. Drug Information Journal. 23(4). 663–667. 11 indexed citations

13.

Short, Charles R., et al.. (1988). Comparison of hepatic drug metabolizing enzyme activities in several agricultural species. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 91(2). 419–424. 36 indexed citations

14.

Weissinger, Judi. (1984). Propranolol can Inhibit the Development of Hypertension in SHR. Clinical and Experimental Hypertension Part A Theory and Practice. 6(6). 1169–1177. 8 indexed citations

15.

Hurwitz, Leon & Judi Weissinger. (1980). Effects of variations in extracellular acetylcholine and calcium ion concentration on the operational level of calcium channels in intestinal smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 214(3). 581–588. 12 indexed citations

16.

Weissinger, Judi, et al.. (1980). Serum Enzyme Abnormalities in Swine Associated withSystemic Infection and Fever. Enzyme. 25(5). 342–345. 1 indexed citations

17.

Weissinger, Judi & Colin M. Bloor. (1980). Heterogeneous response patterns of aortae to norepinephrine.. PubMed. 7(2). 123–38. 2 indexed citations

18.

Fischer, L.J., et al.. (1976). Studies on the biological disposition of diethylstilbestrol in rats and humans. Journal of Toxicology and Environmental Health. 1(4). 587–605. 26 indexed citations

19.

Fischer, Luana, Thomas H. Kent, & Judi Weissinger. (1973). ABSORPTION OF DIETHYLSTILBESTROL AND ITS GLUCURONIDE CONJUGATE FROM THE INTESTINES OF FIVE- AND TWENTY-FIVE-DAY-OLD RATS. Journal of Pharmacology and Experimental Therapeutics. 185(1). 163–170. 18 indexed citations

20.

Fischer, L.J. & Judi Weissinger. (1972). Development in the Newborn Rat of the Conjugation and De-conjugation Processes Involved in the Enterohepatic Circulation of Diethylstilboestrol. Xenobiotica. 2(4). 399–412. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact